Bessemer Group Inc Roivant Sciences Ltd. Transaction History
Bessemer Group Inc
- $61.3 Billion
- Q4 2024
A detailed history of Bessemer Group Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Bessemer Group Inc holds 936 shares of ROIV stock, worth $9,397. This represents 0.0% of its overall portfolio holdings.
Number of Shares
936
Previous 110
750.91%
Holding current value
$9,397
Previous $1,000
1000.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
328Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$661 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$623 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$480 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$443 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$355 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.07B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...